Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
FACT CHECK: Hillary Said 90% of Clinton Foundation Donations go to Charity. Actual Number? 5.7%
Jorge Ramos: "The Future of This Country Will be Composed Solely by Minorities," It's "Beautiful"
John Podesta Wasn't 'Hacked,' He Fell For An Email Phishing Scam
'The System IS Rigged!' Pat Buchanan Goes Off On CNN Propagandist!
Illegal Immigrant Child Molester Flees Guatemala for U.S., Goes on Molestation Spree
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.